Literature DB >> 18772281

Bacterial infection alters the kinetics and function of iNKT cell responses.

Hak-Jong Choi1, Honglin Xu, Yanbiao Geng, Angela Colmone, Hoonsik Cho, Chyung-Ru Wang.   

Abstract

CD1d-restricted Valpha14 invariant NKT cells (iNKT) are innate-like, immunoregulatory lymphocytes that play critical roles in autoimmunity, tumor surveillance, and infectious disease. Although iNKT cells are activated during microbial infection, the impacts of infection on the function of iNKT cells have not been fully characterized. Using a Listeria monocytogenes (LM) infection model, we found that iNKT cells failed to expand after infection, resulting in prolonged loss in the spleen, in contrast to the typical expansion and contraction of conventional T cells. iNKT cells from LM-infected mice responded more rapidly to secondary LM infection; however, they became functionally hyporesponsive to antigenic challenge for at least 1 month. This infection-induced hyporesponsiveness was also induced by Mycobacteria infection and was more profound in LM-infected, thymectomized mice, suggesting that infection-primed iNKT cells might have altered functionality. Interestingly, activation with alpha-galactosylceramide-loaded dendritic cells was able to overcome infection-induced hyporesponsiveness of iNKT cells, suggesting a role for extrinsic factors in this functional deficit. Taken together, these findings suggest that infection affects iNKT cell responses quantitatively and qualitatively. As humans are under constant microbial insult, predictions of iNKT cell function based on naïve animal models may not accurately reflect iNKT cell behavior in a clinical setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772281      PMCID: PMC2614593          DOI: 10.1189/jlb.0108038

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  48 in total

1.  NKT cells and tumor immunity--a double-edged sword.

Authors:  M J Smyth; D I Godfrey
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

2.  Innate recognition of bacteria by a macrophage cytosolic surveillance pathway.

Authors:  Mary O'Riordan; Caroline H Yi; Ramona Gonzales; Kyung-Dall Lee; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-01       Impact factor: 11.205

3.  Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses.

Authors:  J M McNally; C C Zarozinski; M Y Lin; M A Brehm; H D Chen; R M Welsh
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

Authors:  S M Tahir; O Cheng; A Shaulov; Y Koezuka; G J Bubley; S B Wilson; S P Balk; M A Exley
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

5.  Activation of NKT cells protects mice from tuberculosis.

Authors:  Alissa Chackerian; Jen Alt; Vaji Perera; Samuel M Behar
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.

Authors:  Edward E S Nieuwenhuis; Tetsuya Matsumoto; Mark Exley; Robbert A Schleipman; Jonathan Glickman; Dan T Bailey; Nadia Corazza; Sean P Colgan; Andrew B Onderdonk; Richard S Blumberg
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

7.  Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Tiffaney L Vincent; Lan Wu; Luc Van Kaer
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

8.  Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes.

Authors:  Silvia Stockinger; Tilo Materna; Dagmar Stoiber; Lourdes Bayr; Ralf Steinborn; Thomas Kolbe; Hermann Unger; Trinad Chakraborty; David E Levy; Mathias Müller; Thomas Decker
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

9.  Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.

Authors:  J L Matsuda; O V Naidenko; L Gapin; T Nakayama; M Taniguchi; C R Wang; Y Koezuka; M Kronenberg
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

10.  A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas.

Authors:  Nadine Y Crowe; Mark J Smyth; Dale I Godfrey
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  12 in total

1.  Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection.

Authors:  Seung-Jung Kee; Yong-Soo Kwon; Yong-Wook Park; Young-Nan Cho; Sung-Ji Lee; Tae-Jong Kim; Shin-Seok Lee; Hee-Chang Jang; Myung-Geun Shin; Jong-Hee Shin; Soon-Pal Suh; Dong-Wook Ryang
Journal:  Infect Immun       Date:  2012-03-12       Impact factor: 3.441

2.  Autoreactive CD1b-restricted T cells: a new innate-like T-cell population that contributes to immunity against infection.

Authors:  Sha Li; Hak-Jong Choi; Kyrie Felio; Chyung-Ru Wang
Journal:  Blood       Date:  2011-08-22       Impact factor: 22.113

Review 3.  Invariant natural killer T cells: bridging innate and adaptive immunity.

Authors:  Luc Van Kaer; Vrajesh V Parekh; Lan Wu
Journal:  Cell Tissue Res       Date:  2010-08-24       Impact factor: 5.249

4.  Natural Killer T Cells Are Numerically and Functionally Deficient in Patients with Trauma.

Authors:  Young-Goun Jo; Jung-Chul Kim; Hye-Mi Jin; Young-Nan Cho; Seung-Jung Kee; Yong-Wook Park
Journal:  J Innate Immun       Date:  2020-05-25       Impact factor: 7.349

5.  Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function.

Authors:  Manuel Rodríguez-Zapata; Marlene J Matías; Alfredo Prieto; Marco A Jonde; Jorge Monserrat; Lorenzo Sánchez; Eduardo Reyes; Antonio De la Hera; Melchor Alvarez-Mon
Journal:  Infect Immun       Date:  2010-04-19       Impact factor: 3.441

6.  PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.

Authors:  Vrajesh V Parekh; Saif Lalani; Sungjune Kim; Ramesh Halder; Miyuki Azuma; Hideo Yagita; Vipin Kumar; Lan Wu; Luc Van Kaer
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 7.  Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Lan Wu; Luc Van Kaer
Journal:  Expert Rev Vaccines       Date:  2008-12       Impact factor: 5.217

Review 8.  The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products.

Authors:  Luc Van Kaer; Vrajesh V Parekh; Lan Wu
Journal:  Front Immunol       Date:  2015-05-13       Impact factor: 7.561

9.  Group 1 CD1-restricted T cells contribute to control of systemic Staphylococcus aureus infection.

Authors:  Lavanya Visvabharathy; Samantha Genardi; Liang Cao; Ying He; Francis Alonzo; Evgeny Berdyshev; Chyung-Ru Wang
Journal:  PLoS Pathog       Date:  2020-04-28       Impact factor: 6.823

10.  Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Samantha Genardi; Lavanya Visvabharathy; Liang Cao; Eva Morgun; Yongyong Cui; Chao Qi; Yi-Hua Chen; Laurent Gapin; Evgeny Berdyshev; Chyung-Ru Wang
Journal:  Front Immunol       Date:  2020-11-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.